Loading...
The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
Background: There is conflicting data about the increased risk of pulmonary toxicity when granulocyte-stimulating factor (G-CSF) is given in combination with bleomycin. No clear consensus for management of patients with Hodgkin lymphoma (HL) who require G-CSF support exists. Our objective was to eva...
Na minha lista:
| Udgivet i: | Int J Hematol Oncol Stem Cell Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5767288/ https://ncbi.nlm.nih.gov/pubmed/29340124 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|